Latest Headlines
-
Quest Diagnostics Introduces AI Companion To Help Patients Understand And Act On Lab Test Results
3/2/2026
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced Quest AI Companion, a new AI-powered chat feature that helps individuals analyze, understand and act on their Quest laboratory test results with their healthcare provider.
-
Acupath Laboratories, Inc. Partners With Azer Scientific To Install The First AzerView Digital Pathology Scanner In The United States
2/27/2026
Three pathology and healthcare technology leaders today announced a partnership that has resulted in the installation of the first LH510 Digital Pathology scanner in the United States, marking a significant milestone in the advancement of digital pathology and diagnostic innovation.
-
Illumina Whole-Genome Sequencing Technology To Accelerate Rare Disease Testing In Florida
2/27/2026
Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases.
-
ARUP Creates Innovation Central Laboratory To Accelerate Diagnostic Innovation For Biotechnology And Pharmaceutical Partners
2/26/2026
ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners.
-
Thermo Fisher Scientific Introduces New Laboratory Developed Test To Help Transplant Patients Receive The Right Dose Of Critical Anti-Rejection Medication Sooner
2/26/2026
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection.
-
20/20 BioLabs Launches OneTest For Longevity Blood Test And Chronic Disease Risk Assessment And Management Solution Built With IBM AI Capabilities
2/25/2026
20/20 BioLabs (Nasdaq: AIDX), an early market leader in cutting-edge, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announces the launch and commercial availability of its OneTest for Longevity solution.
-
Ultima Genomics And Hamilton Partner To Automate Sample Preparation And Amplification Workflows For The Ultima Family Of Sequencing Systems To Enable Improved Lab Operations And Drive Sequencing At Scale
2/25/2026
Ultima Genomics, a developer of ultra-high-throughput sequencing systems, together with Hamilton (Hamilton Company and Hamilton Bonaduz AG), a global leader in precision laboratory automation, today announced a partnership to automate Ultima's latest sample preparation and amplification technology across Hamilton's Microlab® STAR™ liquid handling platform.
-
Illumina Launches TruPath Genome, Setting A New Standard In Genomic Insight
2/24/2026
Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome insights for genetic disease.
-
Epredia And Mindpeak Announce EU Distribution Agreement For AI-Powered Image Recognition In Cancer Diagnostics
2/24/2026
Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation and Mindpeak, a leading provider of artificial intelligence (AI) solutions for clinical and research pathology, today announced a distribution agreement to bring Mindpeak’s AI-based image recognition software to Epredia’s digital pathology customers in the European Union.
-
Rapid And Accurate Method From VTT For Detecting Hormones, Toxins And Other Small Molecules
2/24/2026
In the field of diagnostics, there has long been a search for solutions to measure low concentrations of small molecules accurately, quickly and easily, for example from food, the environment or a patient sample.